The most popular healthcare and life science company profiles (ranked 6th to 10th) on CB Insights amongst our VC, corporate development, angel investor and investment banking subscribers for November 2010 are given below. Companies ranked 1 to 5 are available only to subscribers who receive comprehensive CB Insights Trends data.
Amira Pharmaceuticals (#10)
Amira Pharmaceuticals is creating anti-inflammatory agents. Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of compounds to treat inflammatory disease linked to the phospholipid pathways. Amira has a strategic partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.
Avila Therapeutics (#9)
Avila Therapeutics is developing new medicines that achieve ‘protein silencing’ based on the proprietary Avilomics platform. Per the company, these medicines, called covalent drugs, strongly and resiliently bond to disease-causing proteins, resulting in therapies that are highly effective against a broad spectrum of human diseases including cancers, autoimmune diseases, and hepatitis C.
SkinMedica is a specialty pharmaceutical company focused on development and commercialization of dermatology drugs and cosmeceuticals that treat dermatologic conditions and improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. Per the company, the formulations in our clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits.
Nevro is developing neuromodulation therapies that aim to provide relief of chronic back pain using Spinal Cord Stimulation (SCS). Per the company, SCS interrupts pain signals before they reach the brain and conventional SCS systems generate paresthesia, an electrical buzzing or tingling sensation, intended to mask pain. Nevro therapy is unique according to the company in that it provides pain relief without paresthesia. The Nevro System has received CE mark and is now commercially available at select centers in Europe
Alder Biopharmaceuticals, Inc. aims to identify, develop, and manufacture antibody therapeutics to alleviate human suffering in the autoimmune and inflammatory disease areas. Alder out-licenses its technologies to Bristol-Myers Squibb, Schering-Plough, Seattle Genetics, and Genmab. Alder’s biologic product for the treatment of rheumatoid arthritis is known as ALD518.
Company profiles ranked 1 to 5 are available to paid subscribers only. Subscribers can click on the above links to view these profiles.
Complete CB Insights Trends data which covers trending companies, investors and industries are provided to paid subscribers for free. Sign up for CB Insights to get access to our extensive venture capital, angel investor and private company database and to receive comprehensive CB Insights Trends.
This report was created with data from CB Insights’ emerging technology insights platform, which offers clarity into emerging tech and new business strategies through tools like:
- Earnings Transcripts Search Engine & Analytics to get an information edge on competitors’ and incumbents’ strategies
- Patent Analytics to see where innovation is happening next
- Company Mosaic Scores to evaluate startup health, based on our National Science Foundation-backed algorithm
- Business Relationships to quickly see a company’s competitors, partners, and more
- Market Sizing Tools to visualize market growth and spot the next big opportunity